NOT-DA-24-037: Notice of NIDA'S Participation in PA-24-248 "PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)"

Notice of NIDA'S Participation in PA-24-248 "PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)"

Notice Number:

NOT-DA-24-037

Key Dates

Release Date:

July 10, 2024

Related Announcements

July 3, 2024 - PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required). See NOFO PA-24-248.

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice informs potential applicants that the National Institute on Drug Abuse (NIDA) will participate in PA-24-248, PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required).

The following sections of PA-24-248 have been modified to reflect NIDA's participation in the NOFO. Changes are made in Bold Italic.

Part 1. Overview Information

Components of Participating Organizations

NATIONAL INSTITUTES OF HEALTH (NIH)

National Eye Institute (NEI)

National Heart, Lung, and Blood Institute (NHLBI)

National Human Genome Research Institute (NHGRI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Deafness and Other Communication Disorders (NIDCD)

National Institute of Environmental Health Sciences (NIEHS)

National Institute of Mental Health (NIMH)

National Institute of Nursing Research (NINR)

National Institute on Minority Health and Health Disparities (NIMHD)

National Library of Medicine (NLM)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute (NCI)

National Institute on Drug Abuse (NIDA)

Assistance Listing Number(s)

93.865, 93.879, 93.113, 93.242, 93.307, 93.273, 93.233, 93.837, 93.838, 93.839, 93.840, 93.866, 93.173, 93.213, 93.286, 93.172, 93.361, 93.393, 93.395, 93.394, 93.867, 93.279

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Elena Koustova, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-497-8768
Email: koustovae@mail.nih.gov